Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference22 articles.
1. Tamura H, Goto R, Akune Y, Hiratsuka Y, Hiragi S, Yamada M. The clinical effectiveness and cost-effectiveness of screening for age-related macular degeneration in Japan: a Markov modeling study. PLoS One. 2015;10:e0133628.
2. Nakae K, Masuda K, Senoo T, Sawa M, Kanai J, Ishibashi T. Aging society and eye disease: a recent epidemiological study on underlying diseases responsible for visual impairment. Geriatr Med. 2006;44:1221–4 (in Japanese).
3. Wako R, Yasukawa T, Kato A, Omori T, Ishida S, Ishibashi T, et al. Causes and prevalence of visual impairment in Japan. Nippon Ganka Gakkai Zasshi. 2014;118:495–501 (in Japanese).
4. Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population: the Hisayama study. Ophthalmology. 2009;116:2135–40.
5. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.